Supporting risk-based prescribing in your busy practice
![Parassess](/sites/default/files/2023-08/NGS_whatstherisk_parassess_3.png)
Appropriate and responsible parasite protection and parasiticide prescribing is under increasing scrutiny.
Veterinary practices can now turn this challenge into an opportunity to better engage with their pet owners.
Parassess® is our free, expert-led, online parasite risk checker for dog owners which could transform parasiticide prescription in your practice.
Watch the video to learn more about the benefits of Parassess® to your practice
For further details, please contact your Boehringer Ingelheim Animal Health Territory Manager or click below to get started with Parassess® in your practice today.
WHAT’S THE RISK? focused practice support
![WHAT’S THE RISK? focused practice support](/sites/default/files/2024-01/WTR_NGS_Laptop_0.png)
Parassess® is a tool developed by Boehringer Ingelheim Animal Health alongside leading experts, to help practices implement the responsible use of parasiticides by:
- Increasing knowledge
- Providing new insight
- Offering practical client support tools
NexGard Spectra® offers benefits for dogs and owners too
Explore the latest...
Owner materials
Handy resources, like posters for your veterinary practice, and materials to support your client communications.
![Owner materials](/sites/default/files/2024-04/New%20owner%20materials%20collection.png)
Puppy campaign
Engage with new puppy owner clients, helping to keep their new family member happy and healthy while building a lifelong connection with your practice.
![Puppy campaign](/sites/default/files/2021-12/blue-box-img2.jpg)
Introducing Parassess®
A FREE online, easy-to-use parasite risk checker that helps owners to help you assess their dog’s individual risk. Enables a timely, risk-based prescribing decision in your busy practice.
![Explore Parassess](/sites/default/files/2024-04/april-2024_It%27s%20time-parassess.jpeg)
- Owner materials
- Puppy campaign
- Parassess risk checker
† NexGard Spectra® also covers heartworm, hookworms, whipworm and eyeworm. NexGard Spectra®’s mite indication is for treatment of sarcoptic mange, demodicosis and otodectes cynotis. NexGard Spectra® does not cover tapeworm.
NexGard Spectra® contains afoxolaner and milbemycin oxime. UK: POM-V IE: POM. Further information available in the SPC or from Boehringer Ingelheim Animal Health UK Ltd., RG12 8YS, UK. UK Tel: 01344 746959 (sales) or 01344 746957 (technical), IE Tel: 01 291 3985 (all queries). Email: vetenquiries@boehringer-ingelheim.com. NexGard Spectra® is a registered trademark of Boehringer Ingelheim Animal Health France SCS, used under licence. Parassess® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH. ©2023 Boehringer Ingelheim Animal Health UK Ltd. All rights reserved. Date of preparation: October 2023. UI-CAN-0129-2023. Use Medicines Responsibly.